Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

Favalli, 2020, COVID-19 infection and rheumatoid arthritis: Faraway, so close!, Autoimmun Rev, 10.1016/j.autrev.2020.102523

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clin Infect Dis, 10.1093/cid/ciaa248

Zhao, 2020, Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study, Am J Roentgenol, 10.2214/AJR.20.22976

Saper, 2019, Emergent high fatality lung disease in systemic juvenile arthritis, Ann Rheum Dis, 78, 1722, 10.1136/annrheumdis-2019-216040

Masters, 2009, Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*), Annu Rev Immunol, 27, 621, 10.1146/annurev.immunol.25.022106.141627

Tanaka, 2014, IL-6 in inflammation, immunity, and disease, Cold Spring Harb Perspect Biol, 6, a016295, 10.1101/cshperspect.a016295

Schulert, 2019, Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors, Arthritis Rheumatol, 71, 1943, 10.1002/art.41073

Mehta, 2020, On behalf of the HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 10.1016/S0140-6736(20)30628-0

Ramos-Casals, 2014, Adult haemophagocytic syndrome, Lancet, 383, 1503, 10.1016/S0140-6736(13)61048-X

clinicaltrials.gov NCT04306705.

El-Maadawy, 2019, Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in Egyptians, Hum Immunol, 80, 208, 10.1016/j.humimm.2018.12.009